Skip to main content
← All BillsCivicRadar

Tuesday, July 7, 2026

Free · Stays on your device

MD · SB435INTRO · 1 COSPONSOR

Public Health - Medetomidine and Xylazine Consumer Protection Act

Where it is in the process
Plain-English Summary

Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain …

Source: OpenStates · fetched April 13, 2026

Votes
Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when MD SB435 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

  • RSS feed· Atom 1.0 + JSON Feed per bill
  • Bluesky· follow a CivicRadar bot post per status change
  • Telegram· channel or DM via bot
  • Discord· channel webhook
  • WhatsApp· via WhatsApp Business
  • SMS· via Twilio